GE Healthcare Technologies Inc
NASDAQ:GEHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
GE Healthcare Technologies Inc
Total Liabilities
GE Healthcare Technologies Inc
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
Total Liabilities
$26.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Liabilities
$19.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Liabilities
$3.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Liabilities
$25.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
13%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Liabilities
$34.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Liabilities
$2.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
16%
|
|
GE Healthcare Technologies Inc
Glance View
GE Healthcare Technologies Inc. operates as a pivotal player in the vast landscape of medical technology, skillfully weaving a narrative that integrates cutting-edge innovation with practical application. As a segment originally spun out from the iconic General Electric Company, GE Healthcare focuses on enhancing diagnostics and patient care through its advanced imaging and monitoring systems. The company's portfolio spans a wide range of products, including magnetic resonance imaging (MRI) machines, ultrasound devices, and computed tomography (CT) scanners, each designed to provide medical professionals with critical insights needed for accurate diagnosis and effective treatment. By leveraging decades of engineering expertise and a rich history in innovation, GE Healthcare not only improves hospital efficiencies but also supports personalized healthcare solutions that help in the early detection and effective management of diseases. Their revenue model is primarily centered around the sale of these high-technology machines and the accompanying service agreements that ensure their seamless operation. Additionally, the company generates income from its work in life sciences, offering a suite of applications and software that assist in drug discovery and bioprocessing. Combining hardware sales with recurring revenue streams from maintenance services and digital solutions enhances the company’s financial stability. This multifaceted approach positions GE Healthcare as both a stalwart in existing medical technology fields and a pioneer exploring the frontiers of healthcare innovations, driven by a mission to improve patient outcomes worldwide.
See Also
What is GE Healthcare Technologies Inc's Total Liabilities?
Total Liabilities
26.5B
USD
Based on the financial report for Dec 31, 2025, GE Healthcare Technologies Inc's Total Liabilities amounts to 26.5B USD.
What is GE Healthcare Technologies Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
23%
Over the last year, the Total Liabilities growth was 8%. The average annual Total Liabilities growth rates for GE Healthcare Technologies Inc have been 13% over the past three years , 23% over the past five years .